Tobacco giant Imperial Brands has selected Blue Yonder as its end-to-end supply chain solution provider.
In addition to other benefits, Blue Yonder's solution will provide Imperial with an integrated and interconnected view of their end-to-end supply chain planning process. This will include strategic scenario planning, demand forecasting, and supply chain and inventory optimization. Imperial will be able to evaluate and execute relevant planning strategies and make more accurate inventory decisions using prescriptive recommendations, thereby improving the customer experience.
As our industry continues to evolve, our company must also continue to evolve, and the supply chain is one of our core areas of transformation. Our strategy is to drive end-to-end supply chain integration in our planning, logistics, and retail businesses. To achieve this goal, we have chosen Blue Yonder as our supply chain solution provider," said Javier Huerta Brands, Chief Supply Chain Officer at Imperial, as quoted in a Blue Yonder press release.
Imperial has been seeking a supply chain solutions provider to lead and transform their business. We are proud to announce that they have chosen Blue Yonder to guide them on this journey," said Phillip Teschemacher, Vice President of Manufacturing for Europe, Middle East, and Africa at Blue Yonder.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
